Literature DB >> 19575509

Deep brain stimulation for the treatment of epilepsy.

Clement Hamani1, Danielle Andrade, Mojgan Hodaie, Richard Wennberg, Andres Lozano.   

Abstract

During the last decade, deep brain stimulation (DBS) has been used to treat several neurologic disorders, including epilepsy. Promising results have been reported with stimulation in different brain regions. At present however, several issues remain unanswered. As an example, it is still unclear whether particular seizure types and syndromes should be treated with DBS in different targets or with different stimulation parameters. In addition, clinical, electrophysiological and anatomical features capable of predicting a good postoperative outcome are still unknown. We review the published literature on DBS, cortical and cerebellar stimulation for the treatment of epilepsy focusing predominantly on the rationale and clinical outcome in each target.

Entities:  

Mesh:

Year:  2009        PMID: 19575509     DOI: 10.1142/S0129065709001975

Source DB:  PubMed          Journal:  Int J Neural Syst        ISSN: 0129-0657            Impact factor:   5.866


  11 in total

1.  Ultrasonic neuromodulation by brain stimulation with transcranial ultrasound.

Authors:  Yusuf Tufail; Anna Yoshihiro; Sandipan Pati; Monica M Li; William J Tyler
Journal:  Nat Protoc       Date:  2011-09-01       Impact factor: 13.491

Review 2.  Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.

Authors:  James J Mahoney; Colleen A Hanlon; Patrick J Marshalek; Ali R Rezai; Lothar Krinke
Journal:  J Neurol Sci       Date:  2020-09-20       Impact factor: 3.181

3.  Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flow.

Authors:  John J Sidtis; Michele Tagliati; Ron Alterman; Diana Sidtis; Vijay Dhawan; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-05       Impact factor: 6.200

4.  High frequency stimulation extends the refractory period and generates axonal block in the rat hippocampus.

Authors:  Zhouyan Feng; Ying Yu; Zheshan Guo; Jiayue Cao; Dominique M Durand
Journal:  Brain Stimul       Date:  2014-04-04       Impact factor: 8.955

5.  Adaptive control of epileptiform excitability in an in vitro model of limbic seizures.

Authors:  Gabriella Panuccio; Arthur Guez; Robert Vincent; Massimo Avoli; Joelle Pineau
Journal:  Exp Neurol       Date:  2013-01-09       Impact factor: 5.330

6.  Functional disconnection of axonal fibers generated by high frequency stimulation in the hippocampal CA1 region in-vivo.

Authors:  Zhouyan Feng; Xiaojing Zheng; Ying Yu; Dominique M Durand
Journal:  Brain Res       Date:  2013-03-06       Impact factor: 3.252

7.  Cerebellar Directed Optogenetic Intervention Inhibits Spontaneous Hippocampal Seizures in a Mouse Model of Temporal Lobe Epilepsy.

Authors:  Esther Krook-Magnuson; Gergely G Szabo; Caren Armstrong; Mikko Oijala; Ivan Soltesz
Journal:  eNeuro       Date:  2014-12

Review 8.  The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy.

Authors:  Yi-Qun Wang; Meng-Qi Zhang; Rui Li; Wei-Min Qu; Zhi-Li Huang
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Effects of anterior thalamic nucleus deep brain stimulation in chronic epileptic rats.

Authors:  Luciene Covolan; Antônio-Carlos G de Almeida; Beatriz Amorim; Clarissa Cavarsan; Maisa Ferreira Miranda; Mayra C Aarão; Ana Paula Madureira; Antônio M Rodrigues; José N Nobrega; Luiz E Mello; Clement Hamani
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

10.  A Simple and Accurate Model to Predict Responses to Multi-electrode Stimulation in the Retina.

Authors:  Matias I Maturana; Nicholas V Apollo; Alex E Hadjinicolaou; David J Garrett; Shaun L Cloherty; Tatiana Kameneva; David B Grayden; Michael R Ibbotson; Hamish Meffin
Journal:  PLoS Comput Biol       Date:  2016-04-01       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.